Pub. Date : 2020 Apr
PMID : 31932237
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Addition of the mTOR inhibitor, everolimus, to exemestane doubled progression-free survival (PFS) in HR+/HER2- MBC patients whose disease had previously progressed during endocrine therapy. | exemestane | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |